Infrared imaging of nitric oxide-mediated blood flow in human sickle cell disease

Microvascular Research

Volumn 84, Issue 3, 2012, Pages 262-269

  Gorbach, Alexander M ^a   Ackerman, Hans C ^b,d   Liu, Wei Min ^a   Meyer, Joseph M ^a   Littel, Patricia L ^c   Seamon, Catherine ^c   Footman, Eleni ^c   Chi, Amy ^c   Zorca, Suzana ^c   Krajewski, Megan L ^c   Cuttica, Michael J ^c,d   Machado, Roberto F ^c,d   Cannon, Richard O ^c   Kato, Gregory J ^c,d  

^a NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CHOLESTEROL; HEMOGLOBIN; HOMOCYSTEINE; N(G) METHYLARGININE; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ACCURACY; ADULT; AREA UNDER THE CURVE; ARTICLE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORE TEMPERATURE; DIASTOLIC BLOOD PRESSURE; FEMALE; FOREARM BLOOD FLOW; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFRARED PHOTOGRAPHY; INTERMETHOD COMPARISON; LUNG ARTERY PRESSURE; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; SICKLE CELL ANEMIA; SKIN BLOOD FLOW; SKIN TEMPERATURE; THERMOGRAPH; TRICUSPID VALVE REGURGITANT VELOCITY; VEIN OCCLUSION PLETHYSMOGRAPHY;

ACETYLCHOLINE; ADULT; ANEMIA, SICKLE CELL; BLOOD FLOW VELOCITY; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; REGRESSION ANALYSIS; RISK; SKIN TEMPERATURE; SPECTROPHOTOMETRY, INFRARED;

EID: 84868131329     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2012.06.011     Document Type: Article

References (40)

1. Adams R.J., McKie V.C., Carl E.M., Nichols F.T., Perry R., Brock K., McKie K., Figueroa R., Litaker M., Weiner S., Brambilla D. Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann. Neurol. 1997, 42:699-704.
2. Adams R., McKie V., Hsu L., Files B., Vichinsky E., Pegelow C., Abboud M., Gallagher D., Kutlar A., Nichols F., Bonds D., Brambilla D. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N. Engl. J. Med. 1998, 339:5-11.
3. Anthi A., Machado R., Jison M., Taveira-Dasilva A., Rubin L., Hunter L., Hunter C., Coles W., Nichols J., Avila N., Sachdev V., Chen C., Gladwin M. Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension. Am. J. Respir. Crit. Care Med. 2007, 175:1272-1279.
4. Aslan M., Ryan T., Adler B., Townes T., Parks D., Thompson J., Tousson A., Gladwin M., Patel R., Tarpey M., Batinic-Haberle I., White C., Freeman B. Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:15215-15220.
5. Beghetti M., Tissot C. Pulmonary arterial hypertension in congenital heart diseases. Semin. Respir. Crit. Care Med. 2009, 30:421-428.
6. Belhassen L., Pelle G., Sediame S., Bachir D., Carville C., Bucherer C., Lacombe C., Galacteros F., Adnot S. Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation. Blood 2001, 97:1584-1589.
7. Berger M., Haimowitz A., Tosh A.V., Berdoff R.L., Goldberg E. Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. J. Am. Coll. Cardiol. 1985, 6:359-365.
8. Bernstein J., Whitten C. A histologic appraisal of the kidney in sickle cell anemia. Arch. Pathol. 1960, 70:407-418.
9. Castro O., Hoque M., Brown B. Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival. Blood 2003, 101:1257-1261.
10. Chien S., King R.G., Kaperonis A.A., Usami S. Viscoelastic properties of sickle cells and hemoglobin. Blood Cells 1982, 8:53-64.
11. Collins F., Orringer E. Pulmonary hypertension and cor pulmonale in the sickle hemoglobinopathies. Am. J. Med. 1982, 73:814-821.
12. de Montalembert M., Aggoun Y., Niakate A., Szezepanski I., Bonnet D. Endothelial-dependent vasodilation is impaired in children with sickle cell disease. Haematologica 2007, 92:1709-1710.
13. Dham N., Ensing G., Minniti C., Campbell A., Arteta M., Rana S., Darbari D., Nouraie M., Onyekwere O., Lasota M., Kato G.J., Gladwin M.T., Castro O., Gordeuk V., Sable C. Prospective echocardiography assessment of pulmonary hypertension and its potential etiologies in children with sickle cell disease. Am. J. Cardiol. 2009, 104:713-720.
14. Eberhardt R., McMahon L., Duffy S., Steinberg M., Perrine S., Loscalzo J., Coffman J., Vita J. Sickle cell anemia is associated with reduced nitric oxide bioactivity in peripheral conduit and resistance vessels. Am. J. Hematol. 2003, 74:104-111.
15. Embury S.H. The clinical pathophysiology of sickle cell disease. Annu. Rev. Med. 1986, 37:361-376.
16. Etteldorf J.N., Tuttle A.W., Clayton G.W. Renal function studies in pediatrics. 1. Renal hemodynamics in children with sickle cell anemia. AMA Am. J. Dis. Child. 1952, 83:185-191.
17. Fonseca G.H.H., Souza R., Salemi V.M.C., Jardim C.V.P., Gualandro S.F.M. Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease. Eur. Respir. J. 2012, 39:112-118.
18. Gladwin M., Kato G. Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia. Hematology 2005, 51-57.
19. Gladwin M., Sachdev V., Jison M., Shizukuda Y., Plehn J., Minter K., Brown B., Coles W., Nichols J., Ernst I., Hunter L., Blackwelder W., Schechter A., Rodgers G., Castro O., Ognibene F. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N. Engl. J. Med. 2004, 350:886-895.
20. Hassan M., Chernomordik V., Vogel A., Hattery D., Gannot I., Little R., Yarchoan R., Gandjbakhche A. Infrared imaging for functional monitoring of disease processes. Medical Infrared Imaging 2007, 14-17. CRC Press, USA, Chapter 14. N. Diakides, J. Bronzino (Eds.).
21. Hatch F.E., Azar S.H., Ainsworth T.E., Nardo J.M., Culbertson J.W. Renal circulatory studies in young adults with sickle cell anemia. J. Lab. Clin. Med. 1970, 76:632-640.
22. Holowatz L.A., Thompson-Torgerson C.S., Kenney W.L. The human cutaneous circulation as a model of generalized microvascular function. J. Appl. Physiol. 2008, 105:370-372.
23. Huie R.E., Padmaja S. The reaction of NO with superoxide. Free. Radic. Res. Commun. 1993, 18:195-199.
24. Ingram V.M. Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin. Nature 1957, 180:326-328.
25. Kato G.J., Wang Z., Machado R.F., Blackwelder W.C., Taylor J.G., Hazen S.L. Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death. Br. J. Haematol. 2009, 145:506-513.
26. Kaul D., Liu X., Fabry M., Nagel R. Impaired nitric oxide-mediated vasodilation in transgenic sickle mouse. Am. J. Physiol. Heart Circ. Physiol. 2000, 278:H1799-H1806.
27. Kaul D., Liu X., Chang H., Nagel R., Fabry M. Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice. J. Clin. Invest. 2004, 114:1136-1145.
28. Landburg P.P., Teerlink T., Biemond B.J., Brandjes D.P.M., Muskiet F.A.J., Duits A.J., Schnog J.B. Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype. Blood Cells Mol. Dis. 2010, 44:229-232. on behalf of the CURAMA Study Group.
29. Maughan R.J., Otani H., Watson P. Influence of relative humidity on prolonged exercise capacity in a warm environment. Eur. J. Appl. Physiol. 2011, 112:1-9.
30. McQuilkin G.L., Panthagani D., Metcalfe R.W., Hassan H., Yen A.A., Naghavi M., Hartley C.J. Digital thermal monitoring (DTM) of vascular reactivity closely correlates with Doppler flow velocity. Conference proceedings: Annual International Conference of the IEEE Engineering in Medicine and Biology Society IEEE Engineering in Medicine and Biology Society Conference 2009 2009, 1100-1103.
31. Morris C.R. Vascular risk assessment in patients with sickle cell disease. Haematologica 2011, 96:1-5.
32. Morris C., Kato G., Poljakovic M., Wang X., Blackwelder W., Sachdev V., Hazen S., Vichinsky E., Morris S., Gladwin M. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA 2005, 294:81-90.
33. Nath K., Shah V., Haggard J., Croatt A., Smith L., Hebbel R., Katusic Z. Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000, 279:R1949-R1955.
34. Ohene-Frempong K., Weiner S., Sleeper L., Miller S., Embury S., Moohr J., Wethers D., Pegelow C., Gill F. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998, 91:288-294.
35. Parent F., Bachir D., Inamo J., Lionnet F., Driss F., Loko G., Habibi A., Bennani S., Savale L., Adnot S., Maitre B., Yaïci A., Hajji L., O'Callaghan D.S., Clerson P., Girot R., Galacteros F., Simonneau G. A hemodynamic study of pulmonary hypertension in sickle cell disease. N. Engl. J. Med. 2011, 365:44-53.
36. Pauling L., Itano H.A., Singer S., Wells I. Sickle cell anemia a molecular disease. Science 1949, 110:543-548.
37. Powars D.R., Elliott-Mills D.D., Chan L., Niland J., Hiti A.L., Opas L.M., Johnson C. Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Ann. Intern. Med. 1991, 115:614-620.
38. Reiter C.D., Wang X., Tanus-Santos J.E., Hogg N., Cannon R.O., Schechter A.N., Gladwin M.T. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat. Med. 2002, 8:1383-1389.
39. Sivamurthy K.M., Dampier C., MacDermott M., Maureen M., Cahill M., Hsu L.L. Peripheral arterial tonometry in assessing endothelial dysfunction in pediatric sickle cell disease. Pediatr. Hematol. Oncol. 2009, 26:589-596.
40. Yuditskaya S., Tumblin A., Hoehn G.T., Wang G., Drake S.K., Xu X., Ying S., Chi A.H., Remaley A.T., Shen R.F., Munson P.J., Suffredini A.F., Kato G.J. Proteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell disease. Blood 2009, 113:1122-1128.